Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression

Background and Objectives: There is evidence for ketamine efficacy in treatment-resistant depression (TRD). Several safety and tolerability concerns arise that some psychotropic agents may provide blood pressure or/and heart rate alterations. The aim of this study is to review blood pressure measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Szarmach, Joanna, Cubała, Wiesław Jerzy, Włodarczyk, Adam, Gałuszko-Węgielnik, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002231/
https://www.ncbi.nlm.nih.gov/pubmed/33809766
http://dx.doi.org/10.3390/medicina57030274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002231/
https://www.ncbi.nlm.nih.gov/pubmed/33809766
http://dx.doi.org/10.3390/medicina57030274

Ejemplares similares